INOZYME PHARMA INC (INZY)
US45790W1080 - Common Stock
| Shares Outstanding | 61.77M |
| Float | 61.35M |
| Owners (insider) | 14.35% |
| Owners (institutional) | 82.92% |
| Owners (insider) change | 0.23% |
| Owners (institutional) change | -0.02% |
Insider Transactions
Top Institutional Holders
Insider Owners
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Apr 2, 2024 | Treco Douglas A | Open Market Sale | 7523 | 6.94 | $ 52,209.62 |
| Apr 1, 2024 | Treco Douglas A | Option Excercise | 25000 | $ 0.00 | |
| Mar 28, 2024 | Winton Matthew | Grant | 3188 | 3.33 | $ 10,616.04 |
| Sep 29, 2023 | Subramanian Sanjay | Grant | 2319 | 3.57 | $ 8,278.83 |
| Aug 1, 2023 | Hopfner Robert Lorne | Open Market Purchase | 833333 | 4.80 | $ 3,999,998.40 |
| Aug 1, 2023 | Pivotal bioVenture Partners Fund I, L.P. | Open Market Purchase | 833333 | 4.80 | $ 3,999,998.40 |
| Aug 1, 2023 | Pivotal bioVenture Partners Fund I G.P., L.P. | Open Market Purchase | 833333 | 4.80 | $ 3,999,998.40 |
| Aug 1, 2023 | Pivotal bioVenture Partners Fund I U.G.P., Ltd | Open Market Purchase | 833333 | 4.80 | $ 3,999,998.40 |
| May 11, 2023 | Hopfner Robert Lorne | Open Market Purchase | 447932 | 6.36 | $ 2,849,997.90 |